8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 10, 2026·SEC
Material company update
Jan 28, 2026·SEC
Assurant, Inc. 5.25% Subordinat(AIZN)Earnings, Financials & Key Ratios
AIZN•NYSE•Insurance & Managed Care
$19.65
$977M mkt cap·1.1× P/E·Price updated May 7, 2026
AboutAssurant, Inc. engages in the provision of lifestyle and housing solutions for consumer purchases. It operates through the following segments: Global Lifestyle, Global Housing, and Corporate and Other. The Global Lifestyle segment offers mobile device solutions and extended service products and related services for mobile devices, consumer electronics and appliances, vehicle protection, and related services. The Global Housing segment includes lender-placed homeowners’ insurance, lender-placed manufactured housing insurance, lender-placed flood insurance, renters' insurance, and related products, voluntary manufactured housing insurance, voluntary homeowners’ insurance and other specialty products. The Corporate and Other segment refers to the corporate employee-related expenses and activities of the holding company. The company was founded in 1892 and is headquartered in Atlanta, GA.Show more
- Revenue$12.81B+7.9%
- Combined Ratio91.51%-0.7%
- Net Income$873M+14.8%
- Return on Equity15.9%+3.7%
- Medical Cost Ratio22.85%-1.9%
- Operating Margin8.49%+8.7%
- Net Margin6.81%+6.4%
- ROA2.45%+10.5%
- Equity / Assets16.18%+11.0%
- Book Value per Share116.97+20.4%
- Tangible BV/Share-149.10+2.5%
- Debt/Equity0.38-7.9%
AIZN Key Insights
Assurant, Inc. 5.25% Subordinat (AIZN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 91.5% combined ratio
- ✓Strong Piotroski F-Score: 7/9
- ✓21 consecutive years of dividend growth
- ✓Momentum leader: RS Rating 94 (top 6%)
- ✓Low loss ratio of 22.8%
- ✓Good 3Y average ROE of 15.1%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AIZN Price & Volume
Assurant, Inc. 5.25% Subordinat (AIZN) stock price & volume — 10-year historical chart
Loading chart...
AIZN Growth Metrics
Assurant, Inc. 5.25% Subordinat (AIZN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.2%
5 Years5.92%
3 Years7.93%
TTM9.02%
Profit CAGR
10 Years19.95%
5 Years14.64%
3 Years46.67%
TTM49.19%
EPS CAGR
10 Years23.84%
5 Years21.02%
3 Years51.01%
TTM53.39%
Return on Capital
10 Years4.17%
5 Years6.78%
3 Years8.75%
Last Year9.27%
AIZN Recent Earnings
Assurant, Inc. 5.25% Subordinat (AIZN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/8 qtrs (100%)●Beat Revenue 3/8 qtrs (75%)
Q1 2026Latest
Feb 10, 2026EPS
$5.61
Est $5.54
+1.3%
Revenue
$3.4B
Est $3.3B
+1.3%
Q4 2025
Nov 4, 2025EPS
$5.18
Est $4.39
+18.0%
Revenue
$3.2B
Est $3.2B
+1.4%
Q3 2025
Aug 5, 2025EPS
$4.56
Est $4.50
+1.3%
Revenue
$3.2B
Est $3.1B
+1.1%
Q2 2025
May 6, 2025EPS
$2.83
Est $2.75
+2.9%
Revenue
$3.1B
Est $3.1B
-0.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $5.61vs $5.54+1.3% | $3.4Bvs $3.3B+1.3% |
| Q4 2025 | Nov 4, 2025 | $5.18vs $4.39+18.0% | $3.2Bvs $3.2B+1.4% |
| Q3 2025 | Aug 5, 2025 | $4.56vs $4.50+1.3% | $3.2Bvs $3.1B+1.1% |
| Q2 2025 | May 6, 2025 | $2.83vs $2.75+2.9% | $3.1Bvs $3.1B-0.1% |
Based on last 8 quarters of dataView full earnings history →
AIZN Peer Comparison
Assurant, Inc. 5.25% Subordinat (AIZN) competitors in Housing and title insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AIZ | 11.64B | 233.70 | 13.44 | 7.89% | 7.6% | 17.4% | 0.38 | |
 PRU | 34.58B | 99.43 | 9.73 | -14.01% | 5.62% | 10.26% | 0.65 | |
 MET | 51.39B | 78.81 | 16.42 | 10.22% | 4.7% | 12.72% | 0.70 | |
 AFL | 58.52B | 113.59 | 16.63 | -8.84% | 21% | 13.05% | 0.29 | |
 UNM | 12.97B | 80.31 | 18.76 | 2.07% | 5.87% | 7.07% | 0.35 | |
 CNO | 4.3B | 45.90 | 19.53 | 0.94% | 4.94% | 8.6% | 1.54 | |
 ESNT | 6B | 61.59 | 8.99 | 12.03% | 53.73% | 12.25% | 0.09 | |
 NMIH | 2.94B | 38.58 | 7.84 | 8.39% | 55.07% | 15.8% | 0.16 |
Compare AIZN vs Peers
Assurant, Inc. 5.25% Subordinat (AIZN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AIZN Income Statement
Assurant, Inc. 5.25% Subordinat (AIZN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.31B | 8B | 9.53B | 9.61B | 10.19B | 10.19B | 11.13B | 11.88B | 12.81B | 13.16B |
| Revenue Growth % | -11.21% | 26.77% | 19.11% | 0.85% | 6% | 0.05% | 9.21% | 6.7% | 7.89% | 9.02% |
| Medical Costs & Claims | 3.21B | 4.64B | 5.62B | 5.95B | 6.04B | 2.36B | 2.52B | 2.77B | 2.93B | 2.92B |
| Medical Cost Ratio % | 50.87% | 58.04% | 59% | 61.88% | 59.27% | 23.15% | 22.65% | 23.29% | 22.85% | 22.17% |
| Gross Profit | 3.1B▲ 0% | 3.36B▲ 8.3% | 3.91B▲ 16.4% | 3.66B▼ 6.2% | 4.15B▲ 13.3% | 7.83B▲ 88.8% | 8.61B▲ 9.9% | 9.11B▲ 5.8% | 9.89B▲ 8.5% | 10.24B▲ 0% |
| Gross Margin % | 49.13% | 41.96% | 41% | 38.12% | 40.73% | 76.85% | 77.35% | 76.71% | 77.15% | 77.83% |
| Gross Profit Growth % | -56.38% | 8.28% | 16.37% | -6.24% | 13.28% | 88.76% | 9.91% | 5.82% | 8.51% | - |
| Operating Expenses | 2.66B | 3.02B | 3.45B | 3.09B | 3.38B | 7.48B | 7.8B | 8.18B | 8.8B | 9B |
| OpEx / Revenue % | 42.08% | 37.79% | 36.23% | 32.1% | 33.16% | 73.42% | 70.1% | 68.9% | 68.67% | 68.42% |
| Depreciation & Amortization | 115.7M | 126.9M | 125.5M | 142.3M | 171.6M | 182M | 196.4M | 223.5M | 250M | 193.3M |
| Combined Ratio % | 92.96% | 95.83% | 95.23% | 93.98% | 92.43% | 96.57% | 92.75% | 92.19% | 91.51% | 90.58% |
| Operating Income | 444.5M▲ 0% | 333.5M▼ 25.0% | 454.7M▲ 36.3% | 578.1M▲ 27.1% | 771.3M▲ 33.4% | 349.9M▼ 54.6% | 806.8M▲ 130.6% | 927.3M▲ 14.9% | 1.09B▲ 17.3% | 1.24B▲ 0% |
| Operating Margin % | 7.04% | 4.17% | 4.77% | 6.02% | 7.57% | 3.43% | 7.25% | 7.81% | 8.49% | 9.42% |
| Operating Income Growth % | -50.95% | -24.97% | 36.34% | 27.14% | 33.42% | -54.63% | 130.58% | 14.94% | 17.27% | - |
| EBITDA | 560.2M | 460.4M | 580.2M | 720.4M | 942.9M | 531.9M | 1B | 1.15B | 1.34B | 1.43B |
| EBITDA Margin % | 8.88% | 5.75% | 6.09% | 7.5% | 9.26% | 5.22% | 9.01% | 9.69% | 10.44% | 10.89% |
| Interest Expense | 49.5M | 100.3M | 110.6M | 104.5M | 111.8M | 108.3M | 108M | 107M | 109.7M | 111.2M |
| Non-Operating Income | -49.5M | -100.3M | -110.6M | -104.5M | -111.8M | -108.3M | -108M | -107M | -109.7M | -111.2M |
| Pretax Income | 444.5M▲ 0% | 333.5M▼ 25.0% | 454.7M▲ 36.3% | 578.1M▲ 27.1% | 771.3M▲ 33.4% | 349.9M▼ 54.6% | 806.8M▲ 130.6% | 927.3M▲ 14.9% | 1.09B▲ 17.3% | 1.24B▲ 0% |
| Pretax Margin % | 7.04% | 4.17% | 4.77% | 6.02% | 7.57% | 3.43% | 7.25% | 7.81% | 8.49% | 9.42% |
| Income Tax | -75.1M | 80.9M | 148.3M | 58.7M | 168.4M | 73.3M | 164.3M | 167.1M | 214.7M | 239.1M |
| Effective Tax Rate % | -16.9% | 24.26% | 32.61% | 10.15% | 21.83% | 20.95% | 20.36% | 18.02% | 19.74% | 19.29% |
| Net Income | 519.6M▲ 0% | 251M▼ 51.7% | 382.6M▲ 52.4% | 440.8M▲ 15.2% | 1.36B▲ 208.9% | 276.6M▼ 79.7% | 642.5M▲ 132.3% | 760.2M▲ 18.3% | 872.7M▲ 14.8% | 1B▲ 0% |
| Net Margin % | 8.23% | 3.14% | 4.01% | 4.59% | 13.37% | 2.71% | 5.77% | 6.4% | 6.81% | 7.6% |
| Net Income Growth % | -8.09% | -51.69% | 52.43% | 15.21% | 208.94% | -79.69% | 132.28% | 18.32% | 14.8% | 49.19% |
| EPS (Diluted) | 9.39▲ 0% | 4.22▼ 55.1% | 6.14▲ 45.5% | 6.70▲ 9.1% | 10.20▲ 52.2% | 5.05▼ 50.5% | 11.95▲ 136.6% | 14.46▲ 21.0% | 17.39▲ 20.3% | 19.93▲ 0% |
| EPS Growth % | 2.85% | -55.06% | 45.5% | 9.12% | 52.24% | -50.49% | 136.63% | 21% | 20.26% | 53.39% |
| EPS (Basic) | 9.45 | 4.24 | 6.18 | 7.04 | 10.37 | 5.09 | 12.02 | 14.55 | 17.29 | - |
| Diluted Shares Outstanding | 55.31M | 59.55M | 62.31M | 63.18M | 60.12M | 54.78M | 53.78M | 52.58M | 50.2M | 50.2M |
AIZN Balance Sheet
Assurant, Inc. 5.25% Subordinat (AIZN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 31.84B | 41.09B | 44.29B | 44.65B | 33.92B | 33.12B | 33.64B | 35.02B | 36.29B | 33.55B |
| Asset Growth % | 7.18% | 29.04% | 7.79% | 0.81% | -24.03% | -2.37% | 1.56% | 4.12% | 3.62% | 5.96% |
| Total Investment Assets | 12.3B | 15.09B | 16.59B | 8.22B | 8.67B | 7.52B | 8.22B | 8.54B | 10.06B | 4M |
| Long-Term Investments | 11.06B | 13.69B | 15.13B | 7.4B | 1.21B | 1.09B | 6.11B | 1.09B | 7.34B | 33.28B |
| Short-Term Investments | 9.95B | 11.63B | 12.72B | 7.11B | 7.46B | 6.44B | 2.11B | 7.46B | 2.72B | 8.78B |
| Total Current Assets | 0 | 0 | 0 | 0 | 17.69B | 17.47B | 12.75B | 19.03B | 13.15B | 12.4B |
| Cash & Equivalents | 996.8M | 1.25B | 1.87B | 2.21B | 2.04B | 1.54B | 1.63B | 1.81B | 1.83B | 1.59B |
| Receivables | 11.15B | 10.81B | 11.29B | 8.15B | 8.19B | 9.49B | 9.01B | 9.76B | 8.6B | 29.1B |
| Other Current Assets | -22.1B | -23.69B | -25.88B | -17.47B | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 1.23B | 6.1B | 4.89B | 4.44B | 12.69B | 13.18B | 13.23B | 13.14B | 13.36B | 42.63B |
| Goodwill | 917.7M | 2.32B | 2.34B | 2.59B | 2.57B | 2.6B | 2.61B | 2.62B | 2.65B | 2.65B |
| Intangible Assets | 313M | 3.78B | 2.54B | 1.85B | 10.11B | 10.58B | 10.62B | 10.53B | 10.71B | 511.1M |
| PP&E (Net) | 347.6M | 392.5M | 433.7M | 446.1M | 561.4M | 645.1M | 685.8M | 768.3M | 841.7M | 0 |
| Other Assets | -12.64B | -20.19B | -20.46B | -12.28B | 1.78B | 738.3M | 862.3M | 991.7M | 1.6B | 19.08B |
| Total Liabilities | 27.56B | 35.96B | 38.61B | 38.7B | 28.46B | 28.89B | 28.83B | 29.91B | 30.42B | 29.9B |
| Total Debt | 1.07B | 2.01B | 2.01B | 2.25B | 2.2B | 2.13B | 2.08B | 2.08B | 2.21B | 2.21B |
| Net Debt | 71.4M | 752M | 139.8M | 45.3M | 161.7M | 593.2M | 453M | 275.4M | 372.8M | 615.8M |
| Long-Term Debt | 1.07B | 2.01B | 2.01B | 2.25B | 2.2B | 1.91B | 2.08B | 2.08B | 2.21B | 2.21B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 224.7M | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 21.73B | 23.74B | 23.47B | 23.96B | 23.89B | 0 |
| Accounts Payable | 3.93B | 3.14B | 3.05B | 1.97B | 2.05B | 2.7B | 2.42B | 2.91B | 2.1B | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 18.62B | 19.8B | 20.11B | 20.21B | 20.88B | 20.9B |
| Other Current Liabilities | -4.29B | -3.48B | -3.59B | -2.67B | 364.2M | 366.6M | 392.7M | 277.7M | 266.4M | -20.9B |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -1.2B | -2.06B | -2.01B | -2.25B | 4.52B | 3.24B | 3.28B | 3.87B | 4.32B | 2.11B |
| Total Equity | 4.28B▲ 0% | 5.13B▲ 19.9% | 5.68B▲ 10.7% | 5.95B▲ 4.8% | 5.46B▼ 8.2% | 4.23B▼ 22.6% | 4.81B▲ 13.7% | 5.11B▲ 6.2% | 5.87B▲ 15.0% | 5.87B▲ 0% |
| Equity Growth % | 4.48% | 19.91% | 10.68% | 4.8% | -8.24% | -22.61% | 13.73% | 6.18% | 14.98% | 46.56% |
| Shareholders Equity | 4.27B | 5.11B | 5.65B | 5.95B | 5.46B | 4.23B | 4.81B | 5.11B | 5.87B | 5.87B |
| Minority Interest | 10.9M | 21.9M | 29.3M | 3.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 4.04B | 5.76B | 5.97B | 3.55B | 4.04B | 3.7B | 4.03B | 4.38B | 4.83B | 4.95B |
| Common Stock | 1.5M | 1.6M | 1.6M | 600K | 700K | 600K | 600K | 500K | 500K | 6.5B |
| Accumulated OCI | 234M | -155.4M | 411.5M | 709.8M | -150M | -986.2M | -765M | -836.1M | -544.2M | -629M |
| Return on Equity (ROE) | 12.4% | 5.33% | 7.07% | 7.58% | 23.85% | 5.71% | 14.22% | 15.33% | 15.9% | 17.4% |
| Return on Assets (ROA) | 1.69% | 0.69% | 0.9% | 0.99% | 3.47% | 0.83% | 1.93% | 2.21% | 2.45% | 2.83% |
| Equity / Assets | 13.45% | 12.49% | 12.83% | 13.34% | 16.11% | 12.77% | 14.3% | 14.58% | 16.18% | 17.5% |
| Debt / Equity | 0.25x | 0.39x | 0.35x | 0.38x | 0.40x | 0.50x | 0.43x | 0.41x | 0.38x | 0.38x |
| Book Value per Share | 77.41 | 86.22 | 91.19 | 94.25 | 90.88 | 77.19 | 89.42 | 97.12 | 116.97 | 116.93 |
| Tangible BV per Share | 55.16 | -16.26 | 12.75 | 24.01 | -120.10 | -163.43 | -156.51 | -152.86 | -149.10 | 53.86 |
AIZN Cash Flow Statement
Assurant, Inc. 5.25% Subordinat (AIZN) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 530.4M | 656.7M | 1.41B | 1.34B | 781.7M | 596.9M | 1.14B | 1.33B | 1.83B | 1.83B |
| Operating CF Growth % | 294.27% | 23.81% | 115.23% | -5.05% | -41.75% | -23.64% | 90.67% | 17.1% | 37.61% | 467% |
| Operating CF / Revenue % | 8.4% | 8.21% | 14.83% | 13.96% | 7.67% | 5.86% | 10.22% | 11.22% | 14.31% | 13.93% |
| Net Income | 519.6M | 251M | 382.6M | 441.8M | 1.37B | 276.6M | 642.5M | 760.2M | 872.7M | 1B |
| Depreciation & Amortization | 115.7M | 126.9M | 125.8M | 144.3M | 171.6M | 182M | 196.4M | 223.5M | 250M | 259.8M |
| Stock-Based Compensation | 35.5M | 57.1M | 55.9M | 57.9M | 66.7M | 62.6M | 75.1M | 81.1M | 0 | 63.2M |
| Deferred Taxes | -4.2M | 20.4M | 89.5M | 191.6M | 131.7M | 63.8M | -108.5M | 244.9M | 0 | 117.2M |
| Other Non-Cash Items | -233.2M | 49.6M | 130.7M | 134.3M | -717.4M | 230.2M | 71.6M | 24M | 298.2M | 45.6M |
| Working Capital Changes | 97M | 151.7M | 628.9M | 372.1M | -243.3M | -218.3M | 261M | -1M | 413M | 195.8M |
| Cash from Investing | -541.2M | -2.2B | -619.8M | -735.2M | 157.6M | -262.1M | -637.7M | -657.8M | -1.46B | -1.32B |
| Capital Expenditures | -62.1M | -82.8M | -110.3M | -121.2M | -187.4M | -186.3M | -202.5M | -221.3M | -235.5M | -182.1M |
| Acquisitions | -129.1M | -1.05B | -7.6M | -531.9M | 1.3B | -67.7M | -300K | -17.9M | -23.5M | -23.5M |
| Purchase of Investments | -4.34B | -6.32B | -4.34B | -2.59B | -3.2B | -3.2B | -2.29B | -2.48B | -3.38B | -2.44B |
| Sale/Maturity of Investments | 4B | 5.34B | 3.88B | 2.45B | 2.5B | 3.23B | 1.89B | 2.07B | 2.17B | 1.94B |
| Other Investing | -11.4M | -92.2M | -44M | 58.5M | -256.1M | -39.2M | -32.8M | -16.5M | 6M | -611.6M |
| Cash from Financing | -26.7M | 1.84B | -179.2M | -264.8M | -1.09B | -818.4M | -403.9M | -477.5M | -364.2M | -245.5M |
| Dividends Paid | -119M | -148M | -170M | -173.3M | -162.3M | -150.2M | -152.3M | -155.9M | -168.4M | -127.5M |
| Share Repurchases | -388.9M | -139.3M | -271.8M | -297M | -839.3M | -572.8M | -193.1M | -307.4M | -303.7M | -239.4M |
| Stock Issued | 0 | 276.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | 0 | 1000K | 1000K |
| Other Financing | 30.4M | 25M | 27.1M | -37M | 0 | -19.5M | -6.7M | -14.2M | -13.8M | -300K |
| Net Change in Cash | -35.2M▲ 0% | 257.2M▲ 830.7% | 613.1M▲ 138.4% | 361.5M▼ 41.0% | -173.8M▼ 148.1% | -518.1M▼ 198.1% | 90.7M▲ 117.5% | 180.3M▲ 98.8% | 26.4M▼ 85.4% | 164.5M▲ 0% |
| Exchange Rate Effect | 2.3M | -35M | -1.3M | 19.5M | -23.3M | -34.5M | -5.8M | -17.1M | 14.5M | 4.7M |
| Cash at Beginning | 1.03B | 996.8M | 1.25B | 1.87B | 2.23B | 2.05B | 1.54B | 1.63B | 1.81B | 0 |
| Cash at End | 996.8M | 1.25B | 1.87B | 2.23B | 2.05B | 1.54B | 1.63B | 1.81B | 1.83B | 0 |
| Free Cash Flow | 468.3M▲ 0% | 573.9M▲ 22.5% | 1.3B▲ 127.1% | 1.22B▼ 6.3% | 594.3M▼ 51.3% | 410.6M▼ 30.9% | 935.6M▲ 127.9% | 1.11B▲ 18.8% | 1.6B▲ 43.8% | 1.5B▲ 0% |
| FCF Growth % | 850.03% | 22.55% | 127.06% | -6.32% | -51.32% | -30.91% | 127.86% | 18.79% | 43.82% | -4.6% |
| FCF Margin % | 7.42% | 7.17% | 13.67% | 12.7% | 5.83% | 4.03% | 8.4% | 9.36% | 12.47% | 11.4% |
| FCF per Share | 8.47 | 9.64 | 20.91 | 19.32 | 9.88 | 7.5 | 17.4 | 21.14 | 31.84 | 31.84 |
AIZN Key Ratios
Assurant, Inc. 5.25% Subordinat (AIZN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 92.96% | 95.83% | 95.23% | 93.98% | 92.43% | 96.57% | 92.75% | 92.19% | 91.51% | 90.58% |
| Medical Cost Ratio | 50.87% | 58.04% | 59% | 61.88% | 59.27% | 23.15% | 22.65% | 23.29% | 22.85% | 22.17% |
| Return on Equity (ROE) | 12.4% | 5.33% | 7.07% | 7.58% | 23.85% | 5.71% | 14.22% | 15.33% | 15.9% | 17.4% |
| Return on Assets (ROA) | 1.69% | 0.69% | 0.9% | 0.99% | 3.47% | 0.83% | 1.93% | 2.21% | 2.45% | 2.83% |
| Equity / Assets | 13.45% | 12.49% | 12.83% | 13.34% | 16.11% | 12.77% | 14.3% | 14.58% | 16.18% | 17.5% |
| Book Value / Share | 77.41 | 86.22 | 91.19 | 94.25 | 90.88 | 77.19 | 89.42 | 97.12 | 116.97 | 116.93 |
| Debt / Equity | 0.25x | 0.39x | 0.35x | 0.38x | 0.40x | 0.50x | 0.43x | 0.41x | 0.38x | 0.38x |
| Revenue Growth | -11.21% | 26.77% | 19.11% | 0.85% | 6% | 0.05% | 9.21% | 6.7% | 7.89% | 9.02% |
AIZN SEC Filings & Documents
Assurant, Inc. 5.25% Subordinat (AIZN) SEC filings — annual & quarterly reports (10-K, 10-Q)
AIZN Frequently Asked Questions
Assurant, Inc. 5.25% Subordinat (AIZN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Assurant, Inc. 5.25% Subordinat (AIZN) grew revenue by 7.9% over the past year. This is steady growth.
Yes, Assurant, Inc. 5.25% Subordinat (AIZN) is profitable, generating $1.00B in net income for fiscal year 2025 (6.8% net margin).
Dividend & Returns
Yes, Assurant, Inc. 5.25% Subordinat (AIZN) pays a dividend with a yield of 17.07%. This makes it attractive for income-focused investors.
Assurant, Inc. 5.25% Subordinat (AIZN) has a return on equity (ROE) of 15.9%. This is reasonable for most industries.
Industry Metrics
Assurant, Inc. 5.25% Subordinat (AIZN) has a combined ratio of 91.5%. A ratio below 100% indicates underwriting profitability.
Explore More AIZN
Assurant, Inc. 5.25% Subordinat (AIZN) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates